68 related articles for article (PubMed ID: 9778761)
1. Effects of simultaneous administration of desferrioxamine and tacrine in rats.
Belles M; Gomez M; Domingo JL; Sanchez DJ; Mayayo E; Corbella J
Vet Hum Toxicol; 1998 Oct; 40(5):269-72. PubMed ID: 9778761
[TBL] [Abstract][Full Text] [Related]
2. Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity.
Yokel RA; Meurer KA; Hong CB; Dickey KM; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1997 Feb; 25(2):182-90. PubMed ID: 9029049
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
Yokel RA; Ackrill P; Burgess E; Day JP; Domingo JL; Flaten TP; Savory J
J Toxicol Environ Health; 1996 Aug; 48(6):667-83. PubMed ID: 8772805
[TBL] [Abstract][Full Text] [Related]
5. Effects of subchronic desferrioxamine infusion on aluminum toxicity in rabbits.
Melograna JM; Yokel RA
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):411-22. PubMed ID: 6463364
[TBL] [Abstract][Full Text] [Related]
6. An extended-release formulation of desferrioxamine for subcutaneous administration.
Toliyat T; Jorjani M; Khorasanirad Z
Drug Deliv; 2009 Oct; 16(7):416-21. PubMed ID: 19640256
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor.
Wang H; Carlier PR; Ho WL; Lee NT; Pang YP; Han YF
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):211-7. PubMed ID: 10452094
[TBL] [Abstract][Full Text] [Related]
8. The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Yokel RA; Meurer KA; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1996 Jan; 24(1):105-11. PubMed ID: 8825197
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a new model of tacrine-induced hepatotoxicity: role of the sympathetic nervous system and hypoxia-reoxygenation.
Stachlewitz RF; Arteel GE; Raleigh JA; Connor HD; Mason RP; Thurman RG
J Pharmacol Exp Ther; 1997 Sep; 282(3):1591-9. PubMed ID: 9316876
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration.
Grasing K; He S; Yang Y
Pharmacol Biochem Behav; 2009 Nov; 94(1):169-78. PubMed ID: 19698738
[TBL] [Abstract][Full Text] [Related]
11. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
12. Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats.
Rispoli V; Marra R; Costa N; Scipione L; Rotiroti D; De Vita D; Liberatore F; Carelli V
Pharmacol Biochem Behav; 2006 Jul; 84(3):453-67. PubMed ID: 16859739
[TBL] [Abstract][Full Text] [Related]
13. Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field.
Schildein S; Huston JP; Schwarting RK
Neurobiol Learn Mem; 2000 Jan; 73(1):21-30. PubMed ID: 10686121
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation.
Galisteo M; Rissel M; Sergent O; Chevanne M; Cillard J; Guillouzo A; Lagadic-Gossmann D
J Pharmacol Exp Ther; 2000 Jul; 294(1):160-7. PubMed ID: 10871308
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Scopolamine Hydrobromide Trihydrate (CAS No. 6533-68-2) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Mar; 445():1-277. PubMed ID: 12594530
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
[TBL] [Abstract][Full Text] [Related]
17. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
19. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome.
Karanth S; Olivier K; Liu J; Pope C
Toxicol Appl Pharmacol; 2001 Dec; 177(3):247-55. PubMed ID: 11749124
[TBL] [Abstract][Full Text] [Related]
20. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Sep; 460():1-414. PubMed ID: 12587016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
